Document is current
Any future updates will be listed below
-
Authors
Kim, Heejeong
Shin, Jeong-Yong
Ham, Sangwoo
Kim, Ji Hun
Lee, Gum Hwa
Lee, Nae-Eung
Kim, Hee-Tae
Cho, Seok Hyun
Kim, Sangseong
Lee, Yunjong https://orcid.org/0000-0003-0182-2279
-
Funding
Funding for this research was provided by:
Ministry of Science and ICT, South Korea (HU22C0143000022, 2021M3H4A4079521, HI17C1711)
- License Information
-
More Information
Article History
Received: 20 December 2023
Accepted: 4 September 2024
First Online: 10 October 2024
Declarations
:
: All animal experiments were approved by the Ethics Committee of Sungkyunkwan University and were conducted in accordance with all applicable international guidelines (SKKUIACUC2020-05-04-1). The use of human plasma samples was approved by the appropriate institutional review board (SKKU 2018-07-018-001; HY-2021-06-040)).
: Not applicable.
: S.H., and Y.L. are inventors of the patent related to this work (South Korea domestic patent no. 10-2252879, “Method for diagnosing Parkinson’s disease using AIMP2 in blood plasma, composition therefor and kit containing the same”). The authors declare no conflicts of interest.
